These drugs represent the class of therapies called GLP-1 mimetics, initially intended for addressing later-stage diabetes. Semaglutide, a specific brand name of this compound, is now widespread attention due to the https://oneblood721394.wikiexpression.com/7089704/grasping_copyright_glp_1_receptor_agonists_a_in_depth_look